Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

Entrada Therapeutics (TRDA)

Entrada Therapeutics Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:TRDA
DateTimeSourceHeadlineSymbolCompany
24/06/202412:15GlobeNewswire Inc.Entrada Therapeutics Announces $100 Million Registered Direct OfferingNASDAQ:TRDAEntrada Therapeutics Inc
24/06/202411:00GlobeNewswire Inc.Entrada Therapeutics Reports Positive Preliminary Data in Healthy Volunteers from Phase 1 ENTR-601-44-101 Trial for Duchenne Muscular DystrophyNASDAQ:TRDAEntrada Therapeutics Inc
14/06/202421:34Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TRDAEntrada Therapeutics Inc
14/06/202421:33Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TRDAEntrada Therapeutics Inc
13/06/202421:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TRDAEntrada Therapeutics Inc
03/06/202412:00GlobeNewswire Inc.Entrada Therapeutics to Present at Goldman Sachs 45th Annual Global Healthcare ConferenceNASDAQ:TRDAEntrada Therapeutics Inc
20/05/202422:26Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TRDAEntrada Therapeutics Inc
16/05/202421:18Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:TRDAEntrada Therapeutics Inc
16/05/202412:00GlobeNewswire Inc.Entrada Therapeutics to Present at H.C. Wainwright 2nd Annual BioConnect Investor Conference at NASDAQNASDAQ:TRDAEntrada Therapeutics Inc
07/05/202412:10Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:TRDAEntrada Therapeutics Inc
07/05/202412:04Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TRDAEntrada Therapeutics Inc
07/05/202412:00GlobeNewswire Inc.Entrada Therapeutics Reports First Quarter 2024 Financial ResultsNASDAQ:TRDAEntrada Therapeutics Inc
13/03/202411:00GlobeNewswire Inc.Entrada Therapeutics Reports Fourth Quarter and Full Year 2023 Financial ResultsNASDAQ:TRDAEntrada Therapeutics Inc
08/03/202421:36Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TRDAEntrada Therapeutics Inc
08/03/202421:34Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TRDAEntrada Therapeutics Inc
06/03/202421:22Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:TRDAEntrada Therapeutics Inc
06/03/202421:22Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:TRDAEntrada Therapeutics Inc
06/03/202400:47Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TRDAEntrada Therapeutics Inc
06/03/202400:46Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TRDAEntrada Therapeutics Inc
06/03/202400:44Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TRDAEntrada Therapeutics Inc
07/02/202412:00GlobeNewswire Inc.Entrada Therapeutics to Present at Upcoming Investor ConferencesNASDAQ:TRDAEntrada Therapeutics Inc
03/01/202412:16Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TRDAEntrada Therapeutics Inc
03/01/202412:00GlobeNewswire Inc.Entrada Therapeutics Promotes Nathan J. Dowden to PresidentNASDAQ:TRDAEntrada Therapeutics Inc
26/12/202321:35Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TRDAEntrada Therapeutics Inc
21/12/202321:26Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:TRDAEntrada Therapeutics Inc
06/12/202312:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TRDAEntrada Therapeutics Inc
22/11/202316:56Dow Jones NewsEntrada Therapeutics Shares Tumble 27% After FDA Keeps Clinical HoldNASDAQ:TRDAEntrada Therapeutics Inc
22/11/202312:54Dow Jones NewsEntrada: FDA Declines to Lift Hold on Duchenne StudyNASDAQ:TRDAEntrada Therapeutics Inc
22/11/202312:35Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TRDAEntrada Therapeutics Inc
22/11/202312:00GlobeNewswire Inc.Entrada Therapeutics Announces Updates on ENTR-601-44 in Duchenne Muscular DystrophyNASDAQ:TRDAEntrada Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:TRDA

Your Recent History

Delayed Upgrade Clock